Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
AstraZeneca
Dow
Colorcon

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

NIMOTOP Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Nimotop patents expire, and what generic alternatives are available?

Nimotop is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in NIMOTOP is nimodipine. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nimodipine profile page.

US ANDA Litigation and Generic Entry Outlook for Nimotop

A generic version of NIMOTOP was launched as nimodipine by SUN PHARM INDS INC on December 14th, 2019.

Summary for NIMOTOP
Drug patent expirations by year for NIMOTOP
Recent Clinical Trials for NIMOTOP

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rijnstate HospitalPhase 2
Amsterdam University Medical CenterPhase 2
University of TwentePhase 2

See all NIMOTOP clinical trials

Synonyms for NIMOTOP
085N594
1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid isopropyl 2-methoxyethyl ester
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methyloxyethyl 1-methylethyl ester
1,4-Dihydro-2,6-dimethyl-4-(3′-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester
1246815-36-0
2-Methoxyethyl 1-Methylethyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
2-Methoxyethyl-1-methylethyl ester
2,6-dimethyl-4-(3-nitrophenyl)-
2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester
3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3-isopropyl 5-(2-methoxyethyl)
3-Isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #
3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester
66085-59-4
AB00053314_05
AB00053314_06
AB00053314-03
AB00053314-04
AB0012346
AB00513963
AB1009471
AC-8484
AC1L1IAS
AC1Q4G7S
ACT02628
Admon
AKOS005174934
AKOS015852459
ALBB-015317
AN-7970
BAY e 9736
Bay-E 9736
Bay-e-9736
BBL028286
BCP21152
BDBM50101971
Bio1_000118
Bio1_000607
Bio1_001096
Bio2_000117
Bio2_000597
BPBio1_000876
BRD-8407
BRD-A58048407-001-06-3
BRD-A58048407-001-09-7
BRD8407
BRN 0459792
BSPBio_000796
BSPBio_001397
BSPBio_002412
C07267
C21H26N2O7
CAS-66085-59-4
CBiol_001832
CCG-101085
CCG-39340
CHEBI:7575
CHEMBL3197349
CPD002530605
CS-2253
CTK8J9033
D00438
DB00393
DivK1c_006812
DRG-0139
DSSTox_CID_3370
DSSTox_GSID_23370
DSSTox_RID_76998
DTXSID5023370
EG-1961
EINECS 266-127-0
EU-0100891
FT-0082761
FT-0602600
GTPL2523
HMS1361F19
HMS1570H18
HMS1791F19
HMS1922E04
HMS1989F19
HMS2052M05
HMS2089H13
HMS2093G11
HMS2097H18
HMS2234B05
HMS3262D04
HMS3266O22
HMS3369G07
HMS3394M05
HMS3402F19
HMS3657I03
HMS3714H18
HY-B0265
I06-0230
IDI1_033867
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
KBio1_001756
KBio2_000117
KBio2_002403
KBio2_002685
KBio2_004971
KBio2_005253
KBio2_007539
KBio3_000233
KBio3_000234
KBio3_001632
KBioGR_000117
KBioGR_001262
KBioSS_000117
KBioSS_002408
KS-1304
Lopac0_000891
LP00891
LS-131292
MCULE-4717687158
methylethyl 5-[(2-methoxyethyl)oxycarbonyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4 -dihydropyridine-3-carboxylate
MFCD00153848
MLS000069381
MLS000863294
MLS001076550
MLS001424155
MLS002154061
MLS002172461
MLS003899190
MolPort-001-840-190
N-149
N0896
NC00335
NCGC00015714-04
NCGC00015714-05
NCGC00015714-06
NCGC00015714-07
NCGC00015714-08
NCGC00015714-09
NCGC00015714-10
NCGC00015714-11
NCGC00015714-12
NCGC00015714-13
NCGC00015714-16
NCGC00021456-02
NCGC00024675-02
NCGC00024675-03
NCGC00024675-04
NCGC00024675-05
NCGC00024675-06
NCGC00024675-07
NCGC00024675-08
NCGC00024675-09
NCGC00261576-01
Nimodipime,(S)
nimodipine
Nimodipine (Nimotop)
Nimodipine (USAN/INN)
Nimodipine [USAN:BAN:INN]
Nimodipine [USAN:USP:INN:BAN]
Nimodipine for peak identification, EuropePharmacopoeia (EP) Reference Standard
Nimodipine-d7
Nimodipine, British Pharmacopoeia (BP) Reference Standard
Nimodipine, European Pharmacopoeia (EP) Reference Standard
Nimodipine, Pharmaceutical Secondary Standard; Certified Reference Material
Nimodipine, United States Pharmacopeia (USP) Reference Standard
Nimodipino
Nimodipino [INN-Spanish]
Nimodipinum
Nimodipinum [INN-Latin]
NimoGel
NIMOTOP (TN)
Nimotop(TM)
Nimotop|||Admon|||BAY-e 9736
NimoVent
NSC-758476
NSC758476
Nymalize
Nymalize (TN)
O5-(2-methoxyethyl) O3-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Opera_ID_14
Periplum
Periplum, Nimotop, BRN 0459792, DRG-0139
Pharmakon1600-01503600
Prestwick0_000918
Prestwick1_000918
Prestwick2_000918
Prestwick3_000918
PubChem16211
R2304
s1747
SAM001246890
SBI-0050866.P003
SC-17122
SCHEMBL34041
SMR000058300
SMR002530605
SPBio_001464
SPBio_002985
SpecPlus_000716
Spectrum_001880
SPECTRUM1503600
Spectrum2_001562
Spectrum3_000766
Spectrum4_000791
Spectrum5_001687
SR-01000075335
SR-01000075335-1
SR-01000075335-2
SR-01000075335-4
SR-01000075335-5
SR-01000075335-7
ST082783
STK642934
SW219238-1
Tox21_110202
Tox21_110202_1
Tox21_500891
UIAGMCDKSXEBJQ-UHFFFAOYSA-N

US Patents and Regulatory Information for NIMOTOP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NIMOTOP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988   Start Trial   Start Trial
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988   Start Trial   Start Trial
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Merck
Johnson and Johnson
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.